Jeff Yass’s Veraxa Biotech Warrants VRXAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.81K Buy
46,684
+36,417
+355% +$3.81K ﹤0.01% 13319
2026
Q2
$1.13K Buy
+10,267
New +$1.81K ﹤0.01% 13241

Other funds holding VRXAW

Jeff Yass's VRXAW Position: Q3 2026 in Review

Jeff Yass increased its Veraxa Biotech Warrants (VRXAW) stake by 355% in Q3 2026, buying an estimated $3.81K and bringing the position to 46,684 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #13319.

Jeff Yass first reported a position in VRXAW in Q2 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold VRXAW as of Q3 2026.

  • Jeff Yass held 46,684 shares of Veraxa Biotech Warrants worth $2.81K as of Q3 2026.
  • Jeff Yass bought 36,417 Veraxa Biotech Warrants shares in Q3 2026, an estimated $3.81K.
  • Veraxa Biotech Warrants made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13319 holding.
  • Jeff Yass first reported a position in Veraxa Biotech Warrants in Q2 2026 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held Veraxa Biotech Warrants as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.